Among the training cohort, significant differences were identified between CR and non‐CR patients in HE4 levels, maximum tumor diameter, total bilirubin, PCOS, insulin resistance, Ki‐67 levels, and myometrial invasion. The gene discussed is MKI67; the disease is polycystic ovary syndrome.